Acceleron Pharma Inc.
USPTO Trademark & Patent Filings
Trademark applications and grants for Acceleron Pharma Inc.. Acceleron Pharma Inc. has 13 trademark applications. The latest application filed is for "AKROVYSS"
- Company Aliases
- Acceleron Pharma Inc.
- Acceleron Pharma, Inc.
- Acceleron Pharma Inc. - Cambridge MA US
| State Incorporated | DELAWARE |
| Entity Type | CORPORATION |
| Address | 128 Sidney Street Cambridge, MASSACHUSETTS UNITED STATES 02139 |
Trademarks Patents
| Patent Application | Date |
|---|---|
| VARIANT ACTRIIB PROTEINS AND USES THEREOF 20220306724 - 17/687934 Kumar; Ravindra ; et al. | 2022-09-29 |
| ALK1 RECEPTOR AND LIGAND ANTAGONISTS AND USES THEREOF 20220296708 - 17/546983 Grinberg; Asya ; et al. | 2022-09-22 |
| ALK7 ANTAGONISTS AND USES THEREOF 20220289852 - 17/505124 Knopf; John ; et al. | 2022-09-15 |
| VARIANTS DERIVED FROM ACTRIIB AND USES THEREFOR 20220281951 - 17/578792 Knopf; John ; et al. | 2022-09-08 |
| COMPOSITIONS AND METHOD FOR TREATING KIDNEY DISEASE 20220259297 - 16/334680 KUMAR; Ravindra ; et al. | 2022-08-18 |
| NCAGE Code | 623P9 | ACCELERON PHARMA INC. |
| CAGE Code | 623P9 | ACCELERON PHARMA INC. |
| SEC | 0001280600 | ACCELERON PHARMA INC of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 